Literature DB >> 28696200

Vaccination Coverage Among Adults Aged 65 and Over: United States, 2015.

Tina Norris, Anjel Vahratian, Robin A Cohen.   

Abstract

KEY
FINDINGS: Data from the National Health Interview Survey ? Among adults aged 65 and over, more than two-thirds had an influenza vaccine in the past 12 months (69.0%). ? More than one in two adults aged 65 and over had a tetanus vaccine in the past 10 years (56.9%). ? More than 6 of 10 adults aged 65 and over had ever had a pneumococcal vaccine (63.6%), while a little more than one-third had ever had a shingles vaccine (34.2%). ? Among adults aged 65 and over, vaccination coverage was highest for non-Hispanic white adults compared with non- Hispanic black and Hispanic adults. ? Vaccination coverage was lowest among poor adults aged 65 and over. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28696200

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  8 in total

Review 1.  Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.

Authors:  Andrew D Wiese; Marie R Griffin; Carlos G Grijalva
Journal:  Expert Rev Vaccines       Date:  2019-03-20       Impact factor: 5.217

Review 2.  Etiology of community-acquired pneumonia in adults: a systematic review.

Authors:  Saeed Shoar; Daniel M Musher
Journal:  Pneumonia (Nathan)       Date:  2020-10-05

3.  Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study.

Authors:  Nicola Veronese; Giusy Vassallo; Maria Armata; Laura Cilona; Salvatore Casalicchio; Roberta Masnata; Claudio Costantino; Francesco Vitale; Giovanni Maurizio Giammanco; Stefania Maggi; Shaun Sabico; Nasser M Al-Daghri; Ligia J Dominguez; Mario Barbagallo
Journal:  Vaccines (Basel)       Date:  2022-04-03

4.  Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.

Authors:  Angel Vila-Córcoles; Olga Ochoa-Gondar; Cinta de Diego; Eva Satué; Angel Vila-Rovira; Maria Aragón
Journal:  Euro Surveill       Date:  2019-07

Review 5.  Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.

Authors:  Angelika Wagner; Birgit Weinberger
Journal:  Front Immunol       Date:  2020-04-23       Impact factor: 7.561

6.  Clinical outcomes and healthcare costs of inpatients with tetanus in Korea, 2011-2019.

Authors:  Sook-In Jung; Hyun-Ha Chang; Sohyun Bae; Minsik Go; Yoonjung Kim; Soyoon Hwang; Shin-Woo Kim; Ki Tae Kwon
Journal:  BMC Infect Dis       Date:  2021-03-09       Impact factor: 3.090

7.  Geographic Heterogeneity in Influenza and Pneumonia Mortality in Hispanic Americans.

Authors:  Annika Diaz-Campbell; Mahbubur Sumon; Alem Mehari; Mackenzie B Snead; Rafael Ramirez; Elizabeth Arend; Richard F Gillum
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390

8.  Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis.

Authors:  Louise Lansbury; Benjamin Lim; Tricia M McKeever; Hannah Lawrence; Wei Shen Lim
Journal:  EClinicalMedicine       Date:  2022-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.